prescription. One patient, one compound. I've worked in hospitals
where if you faxed a script to a 503A compounder by 3 p.m., you'd
have the drug by 5 p.m.
503Bs, on the other hand, must register with the FDA as an out-
sourcing facility — only 64 in the United States have done so
(osmag.net/kxNX8Q). 503Bs are more like pharmaceutical manu-
facturers. They don't need a prescription. They'll manufacture
10,000 vials of propofol in anticipation of their surgical customers
wanting to stock their shelves with a month's worth of syringes.
You want a 503B pharmacy.
A quick word on price. First, expect to pay $9 to $12 a syringe,
depending on the drug and the quantity you buy. Second, you never
want the conversation about cost to infer that you want your phar-
macy to cut corners so that it can give you a better price. For
example, you'll promise them the contract if they'll drop their price
by 15%. Sure, that might work, but maybe the pharmacy stops ter-
minal sterilization and simply aseptically fills.
With increasing regulatory pressure, treatment
shortages, and the need to do more with less, a
KLJKTXDOLW\SUHĠOOHGV\ULQJHSDUWQHU
is more important than ever.
With increasing regulatory pressure, treatment
shortages, and the need to do more with less, a
KLJKTXDOLW\SUHĠOOHGV\ULQJHSDUWQHU
is more important than ever.
